Stocks that helped PMSes focused on smallcaps, midcaps outperform in March SECTIONS Share Synopsis Saurabh Mukherjea, Founder, Marcellus Investment Managers, thinks Indian specialty chemicals today is where the pharma sector stood in the mid-1990s -- on the cusp of a golden 20-year run. Getty Images Some multicap PMSes, which have larger allocation to midcap and smallcap stocks, also performed well in March, continuing from the earlier months. That was even when their benchmarks finished largely flat for the month. Related NEW DELHI: Smallcap and midcap-focused PMS schemes outperformed their peers by a vast margin for yet another month, as the equity market favoured smaller names vis-à-vis the larger ones in March.